Abstract
This paper describes the development of a lyophilized cold kit of DOTA-[Tyr3]-Octreotide (DOTA-TOC) for instant compounding of 68Ga-DOTA-TOC, suitable for diagnosis of neuroendocrine tumors. The work involved formulation of DOTA-TOC kits, optimization of radiolabeling, quality control of 68Ga-DOTA-TOC and animal biodistribution studies. The prepared kits enable a reliable method for preparation of 68Ga-DOTA-TOC of high radiochemical purity and excellent stability. Availability of such kits along with 68Ge/68Ga generators is expected to stimulate the widespread use of 68Ga-DOTA-TOC in nuclear medicine practice in developing countries.
Similar content being viewed by others
References
Velikyan I (2013) Theranostics 4:47
Banerjee SR, Pomper MG (2013) Appl Radiat Isot 76:2
Decristoforo C, Pickett RD, Verbruggen A (2012) Eur J Nucl Med Mol Imaging 39:S31
Breeman WA, de Blois E, Sze Chan H, Konijnenberg M, Kwekkeboom DJ, Krenning EP (2011) Semin Nucl Med 41:314
Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP (2010) Endocr Relat Cancer 17:R53
Fani M, André JP, Maecke HR (2008) Contrast Media Mol Imaging 3:67
Rösch F (2013) Appl Radiat Isot 76:24
Mueller D, Klette I, Baum RP (2013) Recent Results Cancer Res 194:77
Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rösch F (2007) J Nucl Med 48:1741
Gabriel M, Oberauer A, Dobrozemsky G, Decristoforo C, Putzer D, Kendler D, Uprimny C, Kovacs P, Bale R, Virgolini IJ (2009) J Nucl Med 50:1427
Putzer D, Kroiss A, Waitz D, Gabriel M, Traub-Weidinger T, Uprimny C, von Guggenberg E, Decristoforo C, Warwitz B, Widmann G, Virgolini IJ (2013) Eur J Nucl Med Mol Imaging 40:364
Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, Maecke H (2007) Eur J Nucl Med Mol Imaging 34:982
Hofmann M, Maecke H, Börner R, Weckesser E, Schöffski P, Oei L, Schumacher J, Henze M, Heppeler A, Meyer J, Knapp H (2001) Eur J Nucl Med 28:1751
Chakravarty R, Shukla R, Ram R, Venkatesh M, Dash A, Tyagi AK (2010) ACS Appl Mater Interfaces 2:2069
Chakravarty R, Chakraborty S, Ram R, Dash A, Pillai MRA (2013) Cancer Biother Radiopharm 28:631
Chakraborty S, Chakravarty R, Sarma HD, Dash A, Pillai MRA (2013) Cancer Biother Radiopharm 28:77
Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, Kovacs P, von Guggenberg E, Bale R, Virgolini IJ (2007) J Nucl Med 48:508
Frilling A, Sotiropoulos GC, Radtke A, Malago M, Bockisch A, Kuehl H, Li J, Broelsch CE (2010) Ann Surg 252:850
Ruf J, Heuck F, Schiefer J, Denecke T, Elgeti F, Pascher A, Pavel M, Stelter L, Kropf S, Wiedenmann B, Amthauer H (2010) Neuroendocrinology 91:101
Schraml C, Schwenzer NF, Sperling O, Aschoff P, Lichy MP, Müller M, Brendle C, Werner MK, Claussen CD, Pfannenberg C (2013) Cancer Imaging 13:63
Gaertner FC, Beer AJ, Souvatzoglou M, Eiber M, Fürst S, Ziegler SI, Brohl F, Schwaiger M, Scheidhauer K (2013) Invest Radiol 48:263
Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C (2013) Recent Results Cancer Res 194:353
Maecke HR, Andrè JP (2007) In: Schubiger PA, Lehmann L, Friebe M (eds) PET chemistry—the driving force in molecular imaging series. Proceedings of the ernst schering foundation symposium, Springer, Berlin, p 215
Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A (2014) Mol Imaging Biol 16:550
Mukherjee A, Korde A, Sarma HD, Samuel G (2014). doi:10.1007/s10967-014-3308-6
Acknowledgments
Research at the Bhabha Atomic Research Centre (BARC) is part of the ongoing activities of the Department of Atomic Energy, India, and is fully supported by government funding. The authors express their sincere thanks to Dr. M.R.A. Pillai, former Head, Radiopharmaceuticals Division, BARC for initiating this work. The authors are thankful to Dr. K.L. Ramakumar, Director (I), RC& I Group, BARC for encouragement and support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mukherjee, A., Pandey, U., Chakravarty, R. et al. Single vial kit formulation for preparation of PET radiopharmaceutical: 68Ga-DOTA-TOC. J Radioanal Nucl Chem 302, 1253–1258 (2014). https://doi.org/10.1007/s10967-014-3643-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-014-3643-7